JR-446

N/A

Report date: 2025/06/27 11:01:58

Base Information

Drug NameJR-446
Drug Alias NameJR-446
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAlpha-N-acetylglucosaminidase replacementsTransferrin receptor protein 1 modulators
TargetsAlpha-N-acetylglucosaminidaseTransferrin receptor protein 1
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJcr Pharmaceuticals Co LtdMedipal Holdings Corp
China Registration ClassN/A

Develop Information

Active CompaniesMedipal Holdings CorpJcr Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A